In the fight against gastrointestinal tumors, the strategy of using drugs that target the ATX/LPA axis signaling pathway may offer a novel therapeutic option in association with common chemotherapy drugs, especially in the treatment of tumors characterized by a high level of fibrosis, such as pancreatic and liver cancer. The gene discussed is ENPP2; the disease is liver cancer.